Australia markets close in 6 hours 12 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
88.49+0.48 (+0.55%)
At close: 04:00PM EDT
88.99 +0.50 (+0.57%)
After hours: 07:27PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close88.01
Bid88.47 x 200
Ask88.65 x 100
Day's range87.60 - 89.52
52-week range85.21 - 125.83
Avg. volume636,595
Market cap21.325B
Beta (5Y monthly)0.23
PE ratio (TTM)21.64
EPS (TTM)4.09
Earnings date06 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend date02 June 2022
1y target est118.30
  • Reuters

    Pfizer vs Moderna battle over COVID vaccine patents begins in UK

    Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday. Pfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke patents held by Moderna, which hit back days later alleging its patents had been infringed. Moderna says Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the COVID-19 pandemic began in late 2019.

  • Insider Monkey

    25 Richest Billionaires in Healthcare Industry

    In this article, we discuss the 25 richest billionaires in healthcare industry. To skip the detailed analysis of the healthcare industry, go directly to the 5 Richest Billionaires in Healthcare Industry. Global Healthcare Industry Outlook and Trends The global healthcare industry is going through a massive transition amid technological advancements, changing patient needs, and demographic […]

  • GlobeNewswire

    BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024

    MAINZ, Germany, April 22, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. EDT (2:00 p.m. CEST) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update. To access the live conference call via telephone, please register via this